Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-030814
Filing Date
2019-08-08
Accepted
2019-08-08 16:21:39
Documents
68
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q - Q2 FY2019 goss-10q_20190630.htm 10-Q 1906722
2 EX-10.2 goss-ex102_47.htm EX-10.2 136366
3 EX-31.1 goss-ex311_9.htm EX-31.1 9273
4 EX-31.2 goss-ex312_6.htm EX-31.2 9264
5 EX-32.1 goss-ex321_8.htm EX-32.1 7762
6 EX-32.2 goss-ex322_7.htm EX-32.2 7768
  Complete submission text file 0001564590-19-030814.txt   7095348

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT goss-20190630.xml EX-101.INS 1423362
8 XBRL TAXONOMY EXTENSION SCHEMA goss-20190630.xsd EX-101.SCH 57094
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE goss-20190630_cal.xml EX-101.CAL 59124
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE goss-20190630_def.xml EX-101.DEF 197245
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE goss-20190630_lab.xml EX-101.LAB 447302
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE goss-20190630_pre.xml EX-101.PRE 342452
Mailing Address 3013 SCIENCE PARK SAN DIEGO CA 92121
Business Address 3013 SCIENCE PARK SAN DIEGO CA 92121 (858) 922-0718
Gossamer Bio, Inc. (Filer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38796 | Film No.: 191009853
SIC: 2834 Pharmaceutical Preparations